Literature DB >> 23413290

Severe rhabdomyolysis associated with a primary cytomegalovirus infection in an immunocompetent patient.

Héloïse Gindre1, Léonard Féasson, Christian Auboyer, Pascal Cathébras.   

Abstract

Virus-induced rhabdomyolysis rarely induces respiratory failure. We discuss here a case of severe rhabdomyolysis with acute respiratory failure secondary to a cytomegalovirus (CMV) primary infection. We report a case of severe acute rhabdomyolysis, leading to respiratory failure and mechanical ventilation, associated with CMV primary infection in a young and otherwise healthy woman. We excluded other aetiologies such as metabolic myopathies, electrolyte disorders or Guillain-Barré syndrome with exhaustive researches. After 1 year, the patient recovered completely, apart from a slight muscle deconditioning. In this report, we compare our patient with five other similar cases found in the literature; our patient had the most severe presentation. The mechanism of acute viral-induced rhabdomyolysis remains elusive.

Entities:  

Mesh:

Year:  2013        PMID: 23413290      PMCID: PMC3603949          DOI: 10.1136/bcr-2012-008140

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients.

Authors:  Christiane Caudie; Arnaud Quittard Pinon; Didier Taravel; Valérie Sivadon-Tardy; David Orlikowski; Flore Rozenberg; Tarek Sharshar; Jean Claude Raphaël; Jean Louis Gaillard
Journal:  J Neurol       Date:  2011-04-24       Impact factor: 4.849

Review 2.  Rhabdomyolysis and acute kidney injury.

Authors:  Xavier Bosch; Esteban Poch; Josep M Grau
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

3.  Polymyositis associated with primary cytomegalovirus infection.

Authors:  M Maeda; A Maeda; H Wakiguchi; N Murakami; T Sata; T Okada; T Kurashige
Journal:  Scand J Infect Dis       Date:  2000

Review 4.  Infectious etiologies of rhabdomyolysis: three case reports and review.

Authors:  U Singh; W M Scheld
Journal:  Clin Infect Dis       Date:  1996-04       Impact factor: 9.079

5.  [A steroid-responsive case of severe rhabdomyolysis associated with cytomegalovirus infection].

Authors:  Keishiro Sato; Makoto Yoneda; Koji Hayashi; Hiroto Nakagawa; Itsuro Higuchi; Masaru Kuriyama
Journal:  Rinsho Shinkeigaku       Date:  2006-05

6.  Cytomegalovirus infection with rhabdomyolysis and myoglobinuria.

Authors:  G S Hughes; R Hunt
Journal:  Ann Intern Med       Date:  1984-08       Impact factor: 25.391

Review 7.  Rhabdomyolysis: a review.

Authors:  Jason D Warren; Peter C Blumbergs; Philip D Thompson
Journal:  Muscle Nerve       Date:  2002-03       Impact factor: 3.217

Review 8.  Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.

Authors:  N Yuki
Journal:  Lancet Infect Dis       Date:  2001-08       Impact factor: 25.071

Review 9.  Reversible respiratory failure due to rhabdomyolysis associated with cytomegalovirus infection.

Authors:  Daigoro Hirohama; Toshio Shimizu; Kazuki Hashimura; Mina Yamaguchi; Mikio Takamori; Yumi Awatsu; Motoyoshi Tsujino; Toshio Mizutani
Journal:  Intern Med       Date:  2008-10-01       Impact factor: 1.271

10.  Cytomegalovirus infection associated with acute pancreatitis, rhabdomyolysis and renal failure.

Authors:  N Yasumoto; M Hara; Y Kitamoto; M Nakayama; T Sato
Journal:  Intern Med       Date:  1992-03       Impact factor: 1.271

  10 in total
  2 in total

1.  Short-Term High-Dose Steroid Therapy in a Case of Rhabdomyolysis Refractory to Intravenous Fluids.

Authors:  Fnu Zarlasht; Mashal Salehi; Alamgir Sattar; Mohammad Abu-Hishmeh; Muzammil Khan
Journal:  Am J Case Rep       Date:  2017-10-17

2.  Severe rhabdomyolysis associated with severe fever with thrombocytopenia syndrome in a married couple: a case report.

Authors:  Osamu Imataki; Makiko Uemura; Hisashi Masugata
Journal:  BMC Infect Dis       Date:  2019-10-24       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.